Clinical implications of C-reactive protein-albumin-lymphocyte (CALLY) index in patients with esophageal cancer.
Ma R, Okugawa Y, Shimura T, Yamashita S, Sato Y, Yin C, Uratani R, Kitajima T, Imaoka H, Kawamura M, Morimoto Y, Okita Y, Yoshiyama S, Ohi M, Toiyama Y.
Ma R, et al. Among authors: kawamura m.
Surg Oncol. 2024 Apr;53:102044. doi: 10.1016/j.suronc.2024.102044. Epub 2024 Feb 5.
Surg Oncol. 2024.
PMID: 38335851